Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) in comparison with the COVID-19 main protease
HV Sudeep
Abstract
Design and development of an effective compound to combat COVID-19 is clearly critical in the current circumstances. Therefore, it is of interest to document the molecular docking analysis data of the cellular receptor Glucose regulated protein 78 (GRP78) with Withaferin A from Withania somnifera in the context of COVID-19 pandemic for further consideration. Here, we report the optimal interaction features of withaferin A, artemisinin, curcumin and andrographolide with the GRP78 receptor having low binding energies (-8.7, -7.89, -6.21 and -6.17 kcal/mol respectively) in this report. In order to gain additional insights, the interaction pattern of compounds with SARS-CoV-2 main protease (Mpro) was studied.
Topics & Concepts
Withaferin AWithania somniferaDocking (animal)ProteaseContext (archaeology)PharmacologyCoronavirus disease 2019 (COVID-19)Computational biologyChemistryBiologyBiochemistryTraditional medicineMedicineEnzymeVeterinary medicineInternal medicinePaleontologyPathologyDiseaseInfectious disease (medical specialty)Alternative medicinePhytochemicals and Medicinal PlantsSARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery Methods